Interacting Drugs |
Tetrabenazine vs CYP2D6 Inhibitors (Strong) |
Security Level |
 |
Mechanism |
CYP2D6 Inhibitors (Strong): May increase the serum concentration of Tetrabenazine. Specifically, concentrations of the active alpha- and beta-dihydrotetrabenazine metabolites may be increased. |
Management |
Tetrabenazine adult dose should be reduced by 50% when starting a strong CYP2D6 inhibitor. Maximum tetrabenazine adult dose is 50 mg/day when used with a strong CYP2D6 inhibitor. |
Tetrabenazine vs CYP2D6 Inhibitors (Strong)
Post Review about Tetrabenazine vs CYP2D6 Inhibitors (Strong) Click here to cancel reply.
Other Interactions of Tetrabenazine
Other Interactions of CYP2D6 Inhibitors (Strong)
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.